Evidence and references reviewed: 10 November 2026.
A persistent cough deserves an explanation, not simply a stronger cough suppressant. This guide separates assessment from symptom relief.
What counts as chronic cough?
In adults, chronic cough generally means more than eight weeks. In children, a cough lasting more than four weeks should be evaluated using a paediatric pathway. Use age-specific assessment.1,2
An acute respiratory infection may leave a cough that takes three to four weeks to settle. This expected course does not justify ignoring deterioration, systemic illness or other features suggesting a serious cause. Reassessment is appropriate when symptoms worsen or fail to improve as expected.3
A practical time-based classification
| Duration | Typical approach | Important qualification |
|---|---|---|
| Acute: under 3 weeks | Often respiratory infection; assess severity, risk and possible complications. | Acute cough with significant breathlessness, blood or systemic illness needs urgent evaluation. |
| Subacute: 3–8 weeks in adults | May be postinfectious, but review trajectory and alternatives. | Do not attribute a worsening or highly symptomatic cough to the preceding virus without assessment. |
| Chronic: over 8 weeks in adults | Structured history, examination, chest X-ray, full blood count, spirometry and selected tests. | Consider treatable traits, medicines, airway disease and specialist review. |
| Persistent cough in children: over 4 weeks | Use a pediatric-specific pathway, differentiating wet and dry cough. | Sudden onset can mean foreign-body aspiration; chronic wet cough needs assessment. |
These time categories guide assessment, but urgency is determined by severity and warning signs, not merely duration. For example, a cough of one day with severe chest pain may be an emergency, while a prolonged stable dry cough may merit scheduled evaluation.1,2,3
Assessment before treatment
BTS recommends a chest radiograph, full blood count and diagnostic spirometry for adult chronic cough, with fractional exhaled nitric oxide when available. The history should review smoking, exposures and medicines, especially ACE inhibitors. Refer unresolved or unexplained cases; CT is not routinely needed.1
Urgent assessment is needed when cough raises concern for conditions such as pneumonia, sepsis, pulmonary embolism or malignancy. A cough syrup should not delay investigation of a serious presentation. Antibiotic decisions depend on the diagnosis and clinical risk, not simply on how inconvenient the cough has become.3
Warning features that need a different pathway
Hemoptysis (coughing up blood), chest pain, severe breathlessness, unexplained weight loss, prolonged fever, repeated pneumonias, worsening oxygen levels or a new concerning chest X-ray can indicate serious infection, pulmonary embolism, malignancy or other disease. Major bleeding, acute chest pain or respiratory distress warrants emergency assessment. Persistent cough after tuberculosis exposure, especially with night sweats, fever or weight loss, requires appropriate public-health-aware evaluation rather than routine cough syrup.1
When cough is associated with new breathlessness or chest discomfort, see our shortness-of-breath warning signs guide. Clinicians may consider chest imaging, oxygen saturation, sputum evaluation or targeted infectious testing according to clinical context.
Treat the relevant cause or trait
- ACE inhibitor exposure: arrange a prescriber-led review and substitution when indicated; improvement can take several weeks.
- Eosinophilic airway disease: inhaled corticosteroids may help selected patients with supporting features. They are not a blanket treatment for unexplained cough.
- Rhinosinusitis: prominent nasal symptoms may justify a trial of an intranasal corticosteroid.
- Productive cough: assess for infection and airway disease, including bronchiectasis, rather than simply suppressing secretions.1
Common chronic-cough patterns and treatable traits
| Potential cause or trait | Clues | Appropriate next step |
|---|---|---|
| ACE inhibitor-related cough | Dry persistent cough following ACE inhibitor use, sometimes after a delayed onset. | Prescriber review; consider an alternative and allow time for resolution. |
| Asthma or eosinophilic bronchitis | Variable cough, wheeze, nocturnal symptoms or supporting eosinophilic biomarkers. | Diagnostic spirometry/FeNO when appropriate; consider targeted ICS if indicated. |
| Chronic rhinosinusitis | Nasal blockage, discharge, smell changes or prominent rhinitis. | Treat symptomatic upper-airway disease rather than all coughs indiscriminately. |
| Reflux-associated cough | Heartburn, regurgitation or documented pathological reflux. | Address reflux when present, but avoid prolonged empiric PPIs without indication. |
| Bronchiectasis or chronic infection | Persistent productive sputum, repeated infections or abnormal imaging. | Investigate airway disease, microbiology and specialist treatment. |
| Cough hypersensitivity | Cough triggered by talking, fragrances or cold air after other disorders are considered. | Specialist-directed cough-control therapy; selective medicines if needed. |
The British Thoracic Society 2023 clinical statement recommends a treatable-traits approach rather than giving every patient corticosteroids, acid suppressants or antibiotics. Treatment trials should have specific goals and a planned endpoint; lack of response should prompt reassessment rather than indefinite escalation.1
Reflux treatment is not a universal remedy
ERS advises against routine acid-suppressing treatment for chronic cough. Proton pump inhibitors are unlikely to help without reflux symptoms or evidence of acid reflux. Even when reflux is present, improvement is not assured. Treatment trials should have a defined duration and review; ineffective treatment should not continue indefinitely solely because the cough persists.2
Children need a separate pathway
A sudden cough in a previously well young child can indicate an inhaled foreign body. Persistent wet cough raises different possibilities, including protracted bacterial bronchitis. Chest radiography and spirometry, when the child can perform it, may form part of assessment. Selected children may need clinician-directed antibiotics; this is distinct from routine antibiotic use for viral cough.2
What about cough medicines?
For uncomplicated acute cough, antibiotics are usually unnecessary. Bronchodilators and corticosteroids are not routinely indicated without underlying airway disease. Honey may offer limited symptom relief in people older than one year; it must not be given to infants. Evidence for many over-the-counter remedies is limited, and symptomatic improvement does not prove the cause has resolved.3
Prescription cough products containing codeine or hydrocodone are restricted by the FDA to adults aged 18 years and older. Risks include slowed breathing, misuse, addiction, overdose and death. An adult label does not make these medicines a preferred treatment for an unexplained chronic cough.4
What is the role of inhalers, antibiotics and acid suppression?
Inhaled corticosteroids are useful in selected asthma and eosinophilic airway disease, but should not be prescribed indefinitely for unexplained cough without supportive findings or benefit. Bronchodilators are appropriate when airflow obstruction or an established airway condition justifies them, not simply because a dry cough sounds severe.
Antibiotics do not benefit ordinary viral cough. They may be necessary when a specific bacterial infection, pneumonia or pediatric protracted bacterial bronchitis is diagnosed or strongly suspected. Proton pump inhibitors should not be routine therapy without appropriate reflux symptoms/evidence and an agreed review point. Opioid cough medicines bring dependence and respiratory risks and are not first-line therapy for persistent unexplained cough.1,2,3,4
Frequently asked questions
When does a cough become chronic?
More than eight weeks in adults and more than four weeks in children commonly prompts a structured assessment.
Is green sputum proof that I need antibiotics?
No. Color alone does not establish bacterial infection; evaluate the entire presentation.
Should I stop my blood-pressure medicine if I suspect an ACE-inhibitor cough?
Do not self-stop. Ask the prescriber to review and, if appropriate, substitute another medicine.
Is an MRI or CT needed for every chronic cough?
No. BTS recommends chest X-ray and spirometry as part of assessment, with CT selected according to findings and risk.1
Does a cough that continues after a cold always mean infection remains?
No. Postinfectious cough can outlast the virus; worsening or red-flag symptoms still need review.
When cough persists despite treatment
Refractory chronic cough may involve cough hypersensitivity. Specialist care can include cough-control therapy and, in selected adults, carefully monitored neuromodulatory treatment. These options follow assessment and treatment of relevant causes. These are not routine viral-cough treatments.2
A useful review records the intervention, its intended target and whether symptoms improved. Change the plan when the evidence does not support the original explanation, rather than adding treatments indefinitely.
References
- British Thoracic Society. British Thoracic Society Clinical Statement on chronic cough in adults. Thorax. 2023;78(Suppl 6):s3-s19. doi:10.1136/thorax-2023-220592. Available from: https://thorax.bmj.com/content/78/Suppl_6/s3
- European Respiratory Society. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55:1901136. doi:10.1183/13993003.01136-2019. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6942543/
- National Institute for Health and Care Excellence. Cough (acute): antimicrobial prescribing. NICE guideline NG120 [Internet]. 2019 [cited 2026 Nov 9]. Available from: https://www.nice.org.uk/guidance/ng120/chapter/recommendations
- US Food and Drug Administration. FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older [Internet]. 2018 [cited 2026 Nov 9]. Available from: https://www.fda.gov/files/drugs/published/Drug-Safety-Communication–Opioid-Cough-and-Cold-Meds.pdf
⚠️ Medical Disclaimer
This article is intended for educational and informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this article.
The information provided here is based on current scientific literature and established pharmacological principles. However, medical knowledge evolves continuously, and individual patient responses to medications may vary. Healthcare professionals should always use their clinical judgment when applying this information to patient care.
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.